US Patent Issued to CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), UNIVERSITE PARIS-SACLAY on Jan. 13 for "Production and functionalization of nanoparticles derived from phage T5 and therapeutic uses" (French Inventors)

ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,521,432, issued on Jan. 13, was assigned to CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (Paris) and UNIVERSITE PARIS-SACLAY (Saint Aubin, France).

"Production and functionalization of nanoparticles derived from phage T5 and therapeutic uses" was invented by Pascale Boulanger (Limours, France), Emeline Vernhes (Toulouse, France), Nicolas Ducrot (Igny, France), Linda Larbi Cherif (Maisons Alfort, France) and Karim Benihoud (Paris).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to phage T5 capsids that are devoid of genomic DNA from the phage and exposing, on their surface, at least one fusion protein of interest. The i...